The set of selected genes was composed of a group of angiogenesis-related genes (VEGF, PDGF, ANG-1, and PF-4) and genes that have been previously associated with carcinogenic or metastatic processes in breast cancer (WASF3, LAPTM4B, TPM3, and TAC1). This evidence concerns the gene LAPTM4B and breast cancer.